Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments

BACKGROUND: Development of pharmacological treatments to mitigate ischemic heart disease (IHD) has encompassed disappointing results and expensive failures, which has discouraged investment in new approaches to prevention and control. New treatments are most likely to be successful if they act on ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Schooling, C.M., Huang, J.V., Zhao, J.V., Kwok, M.K., Au Yeung, S.L., Lin, S.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835561/
https://www.ncbi.nlm.nih.gov/pubmed/29396305
http://dx.doi.org/10.1016/j.ebiom.2018.01.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835561/
https://www.ncbi.nlm.nih.gov/pubmed/29396305
http://dx.doi.org/10.1016/j.ebiom.2018.01.015

Ejemplares similares